Companies Africa: Aspen pays £700m for GSK’s clotting drugs, Nigerian ...

To view this email as a webpage, click here     Wednesday October 02 2013     African companies   Aspen pays £700m for GSK's clotting drugs   Deal is second-largest this year by sub-Saharan Africa group buying assets outside the continent and allows GSK to focus on profitable new medicines       Nigerian power facilities turn private               Manage email    Forward this email   Feedback    Manage portfolio Subscribe to the FT Follow the FT   Unsubscribe | My Account | RSS | Privacy Policy | About Us | Help   © THE FINANCIAL TIMES LTD 2013 You have received this email because you have signed up from the NBE preference page. This email was sent by a company owned by Pearson plc, registered office at 80 Strand, London WC2R 0RL. Registered in England and Wales with company number 53723.